Skip to main content

Table 1 Tumor size evolution on breast MRI

From: Medical treatment of mammary desmoid-type fibromatosis: which benefit?

IRM date Tumoral size (mm) max/min Tumoral volume (cm3) Evolutiona (%) Medical treatment period/drug(s)
26/10/12 50 × 25 27.4 90.1 22/11/2012–02/07/2013 Tamoxifen 40 mg/day + arthrocine 200 mg/day
18/03/13 50 × 25 27.1 89.1
18/06/13 54 × 26 30.4 100.0
28/11/13 51 × 18 24.7 81.3 02/07/2013–05/09/2013 Sorafenib 400 mg/day
27/06/14 50 × 22 26.5 87.2 05/09/2013–15/01/2015 Sorafenib 200 mg/day
12/12/14 49 × 21 25.6 84.2
21/04/15 49 × 23 26.4 86.9 15/01/2015–09/03/2015 Interferon α2b 5 × 6 106 UI/week
09/03/2015–20/05/2015 Interferon α2b 5 × 6 106 UI/week + arthrocine 200 mg/day
14/01/16 32 × 21 15.3 50.3 30/05/2015–now Sunitinib 25 mg/day by periods of 10 to 15 days
01/07/16 31 × 18 13.2 43.4
  1. aTumoral volume evolution compared to the maximal tumoral volume